US Stock MarketDetailed Quotes

ACRV Acrivon Therapeutics

Watchlist
  • 7.470
  • +0.020+0.27%
Close Jul 15 16:00 ET
  • 7.470
  • 0.0000.00%
Post 16:06 ET
230.65MMarket Cap-2584P/E (TTM)

About Acrivon Therapeutics Company

Acrivon Therapeutics, Inc. develops drugs for clinical treatment. Its unique precision medicine platform is Acrivon Predictive Precision Proteomics (AP3). AP3 is used to generate proprietary OncoSignature companion diagnostics to identify patients who will benefit from the medicine. The company was founded by Peter Blume-Jensen and Kristina Masson in 2018 and is headquartered in Watertown, MA.

Company Profile

SymbolACRV
Company NameAcrivon Therapeutics
Listing DateNov 15, 2022
Issue Price12.50
Founded2018
CEOMr. Peter Blume-Jensen, M.D.,PhD
MarketNASDAQ
Employees61
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address480 Arsenal Way,Suite 100
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Phone1-617-207-8979

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Kristina Masson, M.B.A.,PhD
  • Executive Vice President, Business Operations and Director; President, Chief Executive Officer and Site Head of Acrivon AB
  • 739.78K
  • Peter Blume-Jensen, M.D.,PhD
  • Chairman of the Board, President and Chief Executive Officer
  • 6.47M
  • Dr. Erick Gamelin, M.D.,PhD
  • Chief Development Officer
  • --
  • Rasmus Holm-Jorgensen
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Eric Devroe, PhD
  • Chief Operating Officer
  • --
  • Mary-Alice Miller
  • Chief Legal Officer
  • 697.00K
  • Jean-Marie Cuillerot
  • Chief Medical Officer
  • --
  • Dr. Santhosh Palani, C.F.A.
  • Director
  • --
  • Dr. Ivana Magovcevic-Liebisch, J.D.,PhD
  • Director
  • --
  • Michael J. Tocek, M.B.A.
  • Independent Director
  • 68.13K
  • Dr. Derek DiRocco, PhD
  • Independent Director
  • 65.00K
  • Dr. Charles M. Baum, M.D.,PhD
  • Independent Director
  • 325.07K
  • Dr. Sharon Shacham, M.B.A.,PhD
  • Independent Director
  • 58.13K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg